Physician
Internal Medicine
Dr. James E. Wooldridge, MD
|
|
Give Review
James Wooldridge works in the field of Internal Medicine. He graduated from Tulane University School of Medicine. James Wooldridge is also published. He has 18 publications published. The lastest publication: "Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcRIIIa Patients with Previously Treated Follicular Lymphoma.'
Publications
- Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma.
- A Phase 1 Study of AME-133v (LY2469298) an Fc-Engineered Humanized Monoclonal Antibody in Fc?RIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma.
- A Phase I Clinical Trial of CpG Oligonucleotide 7909 (PF-03512676) in Patients with Previously Treated Chronic Lymphocytic Leukemia.
- Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy...
- A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma.
- Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
- B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
- Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.
- Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.
- Primary cardiac non-Hodgkin's lymphoma diagnosed by transthoracic echocardiography.
- Improved survival of follicular lymphoma patients in the United States.
- Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.
- Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
- Serum alters the uptake and biologic activity of CpG oligodeoxynucleotides in B cell chronic lymphocytic leukemia.
- Optic neuropathy due to anaplastic large cell lymphoma.
- CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response.
- Post-treatment surveillance of patients with lymphoma treated with curative intent.
Schools
Tulane University of Louisiana
University Iowa Hosps and Clin
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Education
-
University of Iowa Hospitals and Clinics -
Tulane University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Shilpa R. Mallur, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam J. Patrick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muniza Masleh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandeep Gupta, MD |
|
|
Dr. Eric A. Benson, MD |
|
|
Dr. Erin V. Newton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amber J. Oberle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abbas Bitar, MD
This Doctor is OpenDoctor Recommended.
|